Meeting abstracts
BAD 2026
British Association of Dermatologists · Manchester, 30 June – 2 July 2026
639 abstracts, published in BJD on 26 June 2026.
- BG01
Impact of cardiovascular–kidney–metabolic syndrome on clinical outcomes in bullous pemphigoid
Wong A, Wang K, … senior author Chung M
- BG10
Herpes simplex virus infection in bullous pemphigoid: diagnostic and management implications
Yuen S, Petrou IA, Coe J
- BG14
Refractory pruritus in older patients: a case of prebullous pemphigoid mimicking folliculitis and generalized eczema
Kongala Arachchige IP, Burova K, … senior author Tan J
- BI12
Two skin diseases, one checkpoint inhibitor: cutaneous toxicity from pembrolizumab
Tan XL, Goiriz R, … senior author Harwood C
- BI17
- BI22
- BI23
Skin checks out: pembrolizumab-associated pemphigoid nodularis
Modak R, Zamani A, … senior author Hadjimichael E
- BI46
Acquired haemophilia A following biologic therapy for dermatological conditions: a systematic review of published case reports
Alomar A, Al Lawati A, Almulla L
- BI49
Vasculopathic cutaneous ulceration as a marker of severe systemic disease in anti-MDA5 dermatomyositis
Khan T, Cunliffe A, O’Neill H
- CPC02
Eosinophilic fasciitis evolving into severe generalized morphoea: a rare spectrum of fibrosing immune disease
Fagan N, Victory L, … senior author Connolly M
- CPC11
Immunobullous crossroads: navigating serological overlap between pemphigus and pemphigoid without paraneoplastic autoimmune multiorgan syndrome
Pandya S, Perks A, … senior author Cain O
- DP14
Clinicopathological correlation in seronegative antiphospholipid syndrome presenting with cutaneous thrombotic microangiopathy
Huerta-Delgado AS, Aboluwarin O, … senior author Shum KW
- P018
A rare case of adolescent lupus vulgaris secondary to neonatal bacille Calmette-Guérin vaccination
Sofela J, Alhadeed F, … senior author Stephens M
- P019
Palbociclib-induced subacute cutaneous lupus erythematosus: a rare clinicopathological case
Shah S, Nagendra S, … senior author Shahid A
- P029
A case of atypical bullous pemphigoid
Liu B, Mistry K, … senior author Skellett AM
- P033
Toxic epidermal necrolysis-like lupus treated with etanercept
Ralph J, Gaffney A, … senior author Alsharqi A
- P045
- P078
- P118
Calcinosis in adult dermatomyositis: association with anti-NXP2 antibodies and distinct anatomical distribution
Wasson E, Connolly A, … senior author Creamer D
- P128
- P136
Dose–response association between antibiotic use and the risk of bullous pemphigoid: a UK population-based case–control study
Hashtrodylar Y, Swiderski M, … senior author Gran S
- P139
Real-world longitudinal rituximab use in pemphigus and pemphigoid: outcomes from a UK tertiary centre
Wong V, Elhag S, … senior author Fremlin G
- P142
Making the invisible visible: national epidemiology reporting of rare dermatological diseases in England
Zhao H, Hardy S, … senior author Venables ZC
- P147
Elevated incidence of autoimmune conditions in people with vitiligo: findings from a large contemporary English cohort
Eleftheriadou V, Cook K, … senior author Ferguson J
- P159
- P160
- P161
Lenalidomide use in refractory cutaneous lupus erythematosus: a UK tertiary centre experience
Chadha M, Vital E, Laws P
- P187
- PD18
That's every abstract.